The Creative Floor Awards winners announced
Area23 and McCann Health win big
Read More
Author: George Underwood
Health driving London’s digital lead in Europe
London leads this increasingly important study by a huge margin, finds new study
Read More
Gilead raises outlook despite dip in revenue
Total revenues were $5.6 billion in 2018 compared to $6.5 billion in 2017
Read More
Lundbeck schizophrenia drug fails Phase III trial
The drug was one of the company’s few original experimental drugs close to reaching the market
Read More
AbbVie assumes full development and commercial control of CF programme
Company announces revised agreement with Galapagos
Read More- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
